京东健康互联网医院
网站导航

上海儿童医院,上海市儿童医院糖尿病性出汗异常专家

简介:

医院由上海市人民政府与世界健康基金会于上世纪九十年代立项建设,1998年正式建成对外开放。国家主席为医院题写院名,时任美国总统夫人希拉里·克林顿女士亲临为医院开张剪彩。2017年医院获批成为国家儿童医学中心。2018年5月,医院建院20周年之际,美国总统唐纳德.特朗普夫妇向医院致以贺信。 医院拥有31个临床科室,规划床位规模1500张,实际开放800张。其主要特色有:1、具有良好的国际化发展背景。医院目前与十多个国家的三十多个国际顶尖医疗机构建立了姐妹合作关系,分别组建了8个国际联合实验室/中心/基地。2、总体疾病诊治疑难度位于市级医院前列。拥有6个国家重点学科、国家临床重点专科和若干省部级重点实验室、研究所。小儿心脏中心、血液肿瘤中心是全球最大的儿童诊治中心,医教研结构完善,代表国内该领域最高学科水平。近年来,医院疾病诊治疑难危重度指数(CMI)位列市级领先。3.医疗质量处于先进水平。2010年成为国内首家通过JCI国际医院认证的儿童专科医院;2018年问鼎上海市政府质量金奖。4、科技创新成果显著。近年来,获得国家自然科学基金数量位列全国儿童专科医院榜首,入围《自然》出版集团中国百强医院,先后以第一单位(或第一合作单位)获得国家科技进步奖8项(占全国儿童医院获奖总数一半以上)。5、积极主动承担社会责任。率先在国内创立医务社会工作部(1998年);率先启动西部、东北地区儿科医护人员培训计划(2002年);率先开展“一带一路”援助计划(2012年);率先开展“无哭声计划”(2014年)……分别获得多个荣誉奖项,并于2017年荣获全国文明单位称号。 上海交通大学医学院附属上海儿童医学中心(简称“儿中心”)是由上海市人民政府与世界健康基金会(Project HOPE)合作共建的一所集医、教、研于一体的三级甲等儿童专科医院。2017年1月,经国家卫计委审批同意,成为国家儿童医学中心的建设主体单位之一。 医院占地面积100亩,总建筑面积约8.4万平方米,规模床位1000张,实际开放床位800张,重症监护床位数配置占总数的1/5。目前,年门急诊总量约192.42万人次,出院病人约4.25万人次,手术病人约2.35万人次。医院拥有多个在国内外具有重要影响力的优势特色学科,如小儿心血管、儿童血液肿瘤、儿童保健(发育行为儿科)。心脏中心是国内建立最早、全球规模最大的小儿先心病诊治中心,儿童血液肿瘤中心已成为国内规模最大的诊治中心。儿童保健(发育行为儿科)专业是我国该学科领域的发源地之一。 医院作为上海交通大学医学院的附属医院,儿科学专业已经成为国家重点学科、211工程、985工程、085工程重点建设学科,相关儿科亚专业相继获得国家临床重点专科、上海市医学重点学科及上海市公共卫生重点学科等。医院还设有国内首家儿科转化医学研究所、卫生部重点实验室、卫生部首批小儿先天性心脏病诊断和介入治疗继续教学的培训基地、上海市小儿先心病研究所、上海市首批临床医学中心,以及儿童听力、儿童血液肿瘤、注意力缺陷、呼吸循环、小儿肝病、儿童癫痫、儿童睡眠障碍等多个研究所及临床诊治中心。20多年来,先后获得国家科技进步二等奖8项(其中合作2项),多次获得上海市科学进步一等奖、中华医学会科技进步奖、教育部科技进步奖、宋庆龄儿科医学奖等重大科研奖励。近年来,医院引进并培养了一批学科骨干,获得中央千人计划、上海市千人计划、国家优青、东方学者、卫生系统领军人才等各类人才资助计划。医院设有儿科专业博士后流动站、博士、硕士培养点,也是上海市儿科和小儿外科住院医师规范化培训的主要基地之一。出汗异常:汗腺支配神经功能障碍是糖尿病自主神经病变的一个常见症状。主要表现为四肢末端少汗,但往往同时伴有躯干部位的多汗。,糖尿病自主神经病变,周围神经系统,胰腺,1.对症治疗糖尿病周围神经病的疼痛症状可口服苯妥英2.病因治疗(1)控制糖尿病(2)肌醇治疗(3)免疫抑制治疗3.促神经代谢和神经营养治疗,首先是对糖尿病的确诊与鉴别。其次是本病应与其他感觉性周围神经病和痛性周围神经病进行鉴别,糖尿病性肌萎缩应与股四头肌肌病、进行性脊髓性肌萎缩以及腰骶神经根病变所引起的股四头肌萎缩相鉴别。,1、忌食辛辣刺激性食物。2、忌食含糖量高的食物。3、忌食油腻食物。,1.血糖及糖耐量测定。 2.其他血液检查包括肝功、肾功、血沉常规检查;风湿系列、免疫球蛋白电泳等与自身免疫有关的血清学检查。 3.血清重金属(铅、汞、砷、铊等)浓度检测。 4.尿液检查包括尿糖、尿常规、本-周蛋白、尿卟啉以及尿内重金属排泄量。 5.脑脊液检查。 6.肌电图和神经电生理检查。 7.必要时组织活检(包括皮肤、腓肠神经、肌肉和肾脏),与其他感觉性周围神经病进行鉴别。,。

杨磊 主治医师

长期从事儿童心脏病的诊断和治疗,包括先天性心脏病、心律失常、川崎病、心肌炎心肌病等;已完成各类儿童心导管检查,包括房间隔缺损、动脉导管未闭、室间隔缺损的介入封堵治疗、肺动脉瓣狭窄介入球囊扩张、以及射频消融术等,具有丰富的临床经验。

好评 100%
接诊量 42
平均等待 30分钟
擅长:长期从事儿童心脏病的诊断和治疗,包括先天性心脏病、心律失常、川崎病、心肌炎心肌病等;已完成各类儿童心导管检查,包括房间隔缺损、动脉导管未闭、室间隔缺损的介入封堵治疗、肺动脉瓣狭窄介入球囊扩张、以及射频消融术等,具有丰富的临床经验。
更多服务
盛王涛 主治医师

擅长早产儿随访,新生儿及婴幼儿黄疸、皮疹、肺炎、喂养、腹泻、便秘、肠绞痛、乳糖不耐受,儿童常见呼吸、消化及感染性疾病诊治。

好评 -
接诊量 3
平均等待 -
擅长:擅长早产儿随访,新生儿及婴幼儿黄疸、皮疹、肺炎、喂养、腹泻、便秘、肠绞痛、乳糖不耐受,儿童常见呼吸、消化及感染性疾病诊治。
更多服务
李伟华 主治医师

待完善

好评 -
接诊量 -
平均等待 -
擅长:待完善
更多服务
周拥 副主任医师

反复呼吸道感染、难治性咳嗽、哮喘、过敏等小儿常见病。

好评 99%
接诊量 1271
平均等待 30分钟
擅长:反复呼吸道感染、难治性咳嗽、哮喘、过敏等小儿常见病。
更多服务
吴佳欐 副主任医师

腺样体肥大,唇腭裂,小儿急慢性鼻炎,过敏性鼻炎,急慢性咽喉炎,小儿急慢性中耳炎,小儿睡眠障碍,发音障碍的诊治,小儿喉气道梗阻的处理,小儿头颈部先天性畸形及头颈肿瘤手术。

好评 100%
接诊量 89
平均等待 6小时
擅长:腺样体肥大,唇腭裂,小儿急慢性鼻炎,过敏性鼻炎,急慢性咽喉炎,小儿急慢性中耳炎,小儿睡眠障碍,发音障碍的诊治,小儿喉气道梗阻的处理,小儿头颈部先天性畸形及头颈肿瘤手术。
更多服务
须丽清 副主任医师

擅长新生儿呼吸道感染、黄疸、各类皮疹、奶蛋白过敏、乳糖不耐受、新生儿喂养问题、早产儿营养、生长发育问题、贫血、胎传梅毒等疾病的诊治。

好评 100%
接诊量 51
平均等待 30分钟
擅长:擅长新生儿呼吸道感染、黄疸、各类皮疹、奶蛋白过敏、乳糖不耐受、新生儿喂养问题、早产儿营养、生长发育问题、贫血、胎传梅毒等疾病的诊治。
更多服务
王依柔 主治医师

尤其擅长特纳综合征,歌舞伎面谱综合征; 儿童矮小症,性早熟等内分泌常见疾病的诊治

好评 100%
接诊量 122
平均等待 2小时
擅长:尤其擅长特纳综合征,歌舞伎面谱综合征; 儿童矮小症,性早熟等内分泌常见疾病的诊治
更多服务
夏泽阳 主治医师

儿童神经外科,狭颅症,肿瘤,脊柱裂,脊髓栓系

好评 100%
接诊量 38
平均等待 1小时
擅长:儿童神经外科,狭颅症,肿瘤,脊柱裂,脊髓栓系
更多服务
乔荆 主任医师

儿童内分泌与遗传代谢(矮小症、性早熟、肥胖症)和疑难杂的诊治。及儿童疾病健康与管理的评估与诊治,特别是未病先防,已病防变。 并带领团队在上海儿童医学中心开设了全国第一个儿童疾病健康管理评估门诊。

好评 95%
接诊量 124
平均等待 3小时
擅长:儿童内分泌与遗传代谢(矮小症、性早熟、肥胖症)和疑难杂的诊治。及儿童疾病健康与管理的评估与诊治,特别是未病先防,已病防变。 并带领团队在上海儿童医学中心开设了全国第一个儿童疾病健康管理评估门诊。
更多服务
宓兰兰 主治医师

主要从事:危重新生儿的临床诊治,包括新生儿呼吸窘迫综合征、支气管肺发育不良、先天性心脏病围手术期管理、新生儿坏死性小肠结肠炎的内科治疗、感染性休克的评估和治疗等;擅长极早产儿、超早产儿的救治、营养管理、生长发育评估等;对新生儿黄疸、新生儿肺炎、新生儿化脓性脑膜炎、糖尿病母亲新生儿等综合治疗有较丰富的临床经验。

好评 -
接诊量 1
平均等待 -
擅长:主要从事:危重新生儿的临床诊治,包括新生儿呼吸窘迫综合征、支气管肺发育不良、先天性心脏病围手术期管理、新生儿坏死性小肠结肠炎的内科治疗、感染性休克的评估和治疗等;擅长极早产儿、超早产儿的救治、营养管理、生长发育评估等;对新生儿黄疸、新生儿肺炎、新生儿化脓性脑膜炎、糖尿病母亲新生儿等综合治疗有较丰富的临床经验。
更多服务

患友问诊

脚后跟干裂,脚底出汗并有酸臭味
9
2024-10-31 06:16:41
足部出汗多,脚部蜕皮,不痒但有味道。患者男性25岁
29
2024-10-31 06:16:41
脚出汗多,脚部有脱皮、水泡和瘙痒症状,想咨询脚气治疗。
13
2024-10-31 06:16:41
脚部瘙痒一年多,使用过抗真菌药膏效果不佳,考虑使用联苯苄唑溶液治疗。
34
2024-10-31 06:16:41
患者脚部出汗,无水泡和伤口,咨询用药建议。
50
2024-10-31 06:16:41
患者,女,15岁,脚部出汗多,已有3个多月,求医用药建议。
6
2024-10-31 06:16:41
大腿内侧出汗多,疑似汗腺炎,寻求用药建议。
23
2024-10-31 06:16:41
患者服用Omega-3补充剂后出汗有氨味,寻求原因和解决方案。
47
2024-10-31 06:16:41
老年人夜间出汗多,伴有胸闷胸痛、气短乏力、心悸、面色不好,无慢性病史和过敏史。
9
2024-10-31 06:16:41
脚部在凉爽环境下也出汗,且出汗较多,询问原因及调理方法。
29
2024-10-31 06:16:41

科普文章

#糖尿病性异常出汗#1型糖尿病性异常出汗
38

夏天气候炎热,人处于高温之下,多汗是一种正常现象。但是有些人特别爱出汗,吃顿饭、做点事常常是满头大汗,稍一紧张就汗流浃背,这种病症在医学上称为多汗症。

引起多汗的原因有很多种,先天遗传、患某些特殊疾病,如:甲亢等,还有一些身体气虚等,对于气阴不足引起的自汗、盗汗及小儿盗汗,也就是气虚所致。可以选择虚汗停颗粒,益气养阴,固表敛汗。另外如果患者,出现了汗多,特别容易感冒,体质虚弱,表虚不固,自汗恶风,面色苍白,对于这类症状可以服用中成药玉屏风颗粒。

另外,对于气虚所致汗多的人,还可以服用西洋参含片、或西洋参泡水喝调理,具有滋阴益气固表的作用。同时饮食上多吃当归黄芪炖排骨,加上大枣,补益气血;可以多喝点山药粥,可以健脾益气,促进脾胃功能,优质蛋白的食物可以多吃点,比如说海参、牛肉、牡蛎、鸽子等,出汗多的时候,要多补充盐和水分,以及钙和维生素 D。

#糖尿病性异常出汗#2型糖尿病性异常出汗
30

一直出汗是什么原因?是困扰着广大群众的一个问题,很多人都会有出汗的情况。但是,总是出汗也可能存在着一些问题,而对于一直出汗也会分为生理情况和病理情况两种,有可能是内分泌因素紊乱的原因而导致的,也有可能是其他的原因,而对于一直出汗具体是什么原因是我们今天学习的内容。

第一,生理性的汗出

  • 出汗一般不是因为疾病而导致的
  • 往往人体在大量运动和激动以及进食热汤或者是食用了辛辣刺激性的食物,这时会刺激交感神经而出现生理性的汗出
  • 在停止运动或者是保持凉爽的环境,这样一直汗出的情况就会得到缓解
  • 对人体也并没有什么伤害,无须特殊的处理

第二,病理性的汗出

  • 病理性的汗出是一直出汗的主要原因
  • 在西医的角度分析主要是内分泌失调紊乱而导致的,比如临床常见的糖尿病会导致患者经常的汗出,也称之为“糖尿病泌汗异常”
  • 在中医的角度分析一直出汗的原因有很多种,其中包括先天不足、饮食不节、劳累疲倦、久病体虚等情况都是导致自汗盗汗的主要原因,表现为头部汗出或者全身汗出以及睡梦中汗出等情况

总结

一直汗出其实是分为生理和病理两种情况的,生理上的无须特殊处理,病理上的应该进行相关的检查包括内分泌的检查,采取一些中西医结合的治疗方法,最终选择一个合适的方案将症状缓解!

#糖尿病性异常出汗#2型糖尿病性异常出汗
11

女性患者出汗多在临床上是比较常见的,出汗的部位也大不相同,有的是全身的大量汗出,而有的是头部或者身体其他部位的汗出较多,对于女性患者经常的出汗多是什么原因大致有以下几个方面!

第一,需要排除器质性病变而导致的出汗较多,比如临床上最为常见的内分泌系统疾病,如:甲状腺功能亢进症、糖尿病、内分泌紊乱等疾病都会导致女性患者出汗较多,有的患者同时会伴有口渴多饮、食量大、身体消瘦、大便次数增多等情况的发生,这时需要对基础疾病和器质性病变进行相关的治疗才能够缓解出汗多的情况。

第二,不良的饮食习惯和生活习惯,比如有的患者会非常爱吃辣的,并且没有良好的作息时间,经常的熬夜、吸烟、饮酒导致体内内环境的紊乱,出现了痰湿体质或者肝阳上亢体质以及阴虚火旺体质和气虚的体质导致泌汗的异常伤及了支配汗腺的植物神经,造成了多汗的情况。

第三,植物神经功能紊乱,女性患者植物神经功能紊乱多发生在围绝经期,一般年龄在 50 岁左右,原因在于更年期时体内雌性激素逐渐的衰竭,这时植物神经功能会发生混乱,很容易出现女性患者多汗的情况,除了多汗还会出现烦躁、心慌、气短、乏力时、失眠多梦等症状,这时需要补充体内的雌性激素,也可以用中医中药的方法进行调理。

#糖尿病性出汗异常#多汗症#中暑
14
 

也许你比别人更爱出汗,但 大部分情况下都跟疾病无关,是很正常的表现,无需过于担心。

影响出汗量的最常见因素就是环境,温度高的时候身体就会出汗散热。 胖人或者皮脂较高的人则更容易出汗。

这是因为脂肪本身不宜散热,相反它可以帮助维持体温恒定,如果说抵御寒冷的话,那么这些脂肪显得十分有用,但面对夏季的炎热时,这些脂肪则会导致体温散热较慢,人体就需要更多的排汗来维持恒温。

很多原本中度肥胖的人群表示在减重成功之后,相对以前肥胖时,夏天就好受很多,冬天则不像以前那么“抗冻”了。

尽管胖人爱出汗,但由于脂肪组织本身含水较少,所以胖人更需要注意补充水份,尤其是运动前后。

再比如,我们平时心情波动、紧张、害怕的时候也会出汗,孕产妇、更年期女性也会有多汗的情况,这些情况也不用过于担心。

#糖尿病性出汗异常#多汗症#中暑
69
首先,出汗多少本身就存在个体差异

汗液来自于汗腺,每个人汗腺的数量是有差异的,甚至男女都有差异,同样的训练强度、时间,汗腺多的人出汗就多。

其次,与体液的多少有关

你可以简单的理解为,有的人爱喝水,或者喝水本身就多,那么它流汗的“资源”也就多,很多不爱流汗的人本身喝水就很少,这是十分不好的习惯。职业运动员一次大强度训练失汗量就可达2-7L,在出汗量增大之后甚至会出现少尿或者无尿的情况。如果平时不喜欢喝水,进行高强度训练的时候则很容易脱水。

有些读者可能认为不爱出汗就是没有水份流失,脱水从何而谈呢?实际上运动中由于呼吸也会加强,一部分水份会随着呼吸而丧失,对于运动爱好者来说,由于水份不足导致的运动能力下降也容易被忽略。

一般建议运动前2小时补充400-600ml的液体,不要豪饮,慢慢喝下。

同时养成观察尿液颜色的习惯,如果尿液颜色偏淡黄近乎白色,则说明你身体的水合情况不错,通俗讲就是不缺水。

有些人习惯用口渴来判断是否需要喝水,这样的判断在高温下是不准确的,因为温度会影响你对于“渴”的敏感。如果本身就不爱喝水,那就下一个提醒你喝水的APP,或者自己上个闹钟。

第三种,运动强度过低或者不大

有些人把出汗分为主动出汗和被动出汗。

比如看个恐怖片吓得冒汗,因为紧张而出汗等等,这些都是被动出汗。而运动则属于主动出汗,运动的时候肌肉产生收缩,血液循环加速,人体体温提高,显然这个出汗是为了保持体温、散热,所以当肌肉活动越发剧烈,运动强度越高,出汗量则越大,如果你觉得自己运动时不爱出汗,不妨试一下提高运动强度。

除此之外,也许和温度相关,现代人室内运动场所几乎都标配空调,温度相比室外凉快了太多,在这样的环境下运动不爱出汗也是正常的。

 

病症: 胃癌 恶性黑色素瘤

患者:李女士

年龄:70岁

罹患癌症,毫无疑问对每个人都是重大打击。而如果一位患者不幸同时罹患两种癌症,我们可以想象得出他的心情会是怎样的沉重。

但时至今日,癌症早已不再是什么“不治之症”,很多良好的治疗方法,可帮助患者迈过重重困境,预后得到极大提升。

不仅如此,在医疗全球化的今天,中国患者也能通过“海外二诊”服务,快速触达到国际权威专家资源,为自己的治疗保驾护航!

今天的案例主人公李女士,正是一位“海外二诊”的受益者。我们来一起看看她的故事。*为保护隐私,文中患者个人信息均已经脱敏处理。

70岁的李女士在去年年底,因脚底疼痛去医院看病,结果发现脚后跟有一个1厘米的黑色肿物。医生判断是冻疮,于是开了点外用药,李女士也就没有再放在心上。

大概4个月后,真正的噩梦降临:李女士通过影像检查,被诊断为胃癌,而且有了淋巴结转移。 她还出现了多次呕血,病情非常危急。很快,医生为她实施了全胃切除。令人意想不到的是,几天后通过检查,医生发现李女士后脚跟的肿物竟然也是癌症——恶性黑色素瘤。于是大概2个月后,医生又切除了她的足底肿瘤。 

为了降低复发风险,李女士开始了3个周期的化疗联合免疫治疗(替吉奥联合纳武单抗)。

虽然该做的都已做完,但对于李女士来说,恐惧感还远未被消除。因为癌症最令人恐惧的,是其具有“复发转移”的能力 。一旦癌症再次袭来,李女士不知道自己该如何应对。另外,两种癌症的治疗以及术后辅助药物治疗,也让李女士遭遇了一些副作用。比如腹泻、味觉障碍还有体重明显下降的问题。这些对于已经70岁的李女士来说,都很影响生活质量,所以迫切需要解决。

在本次的国际专家“海外二诊”服务中,李女士预约的是来自日本某知名综合性医院肿瘤中心的外科部长医生,他的专长领域既包括肿瘤外科,又包括各类癌症药物疗法、姑息治疗,是一位“内外兼修”的权威专家。在充分了解了李女士既往的病情和治疗经过后,医生很快通过远程会诊的方式,为患者详细解答了当前她的所有问题。

1、 未来如果转移或复发了该怎么办?  

医生:假如您未来不幸出现转移或复发,那么化疗是核心治疗手段。对于单发的孤立转移灶,可以选择手术、放疗来进行局部治疗。

具体化疗方案选择,我按使用的先后顺序列出了3类,当前面的方案失效后,可更换为后面的方案。

一类方案:化疗联合/不联合免疫方案  

  • CAPOX (卡培他滨+奥沙利铂)±O药(即免疫药物纳武单抗)
  • SOX (替吉奥+奥沙利铂)±O药
  • FOLFOX (5-FU+奥沙利铂)±O药

二类方案:化疗联合/不联合抗血管药物方案  

  • Taxane (紫杉醇/白蛋白结合型紫杉醇/多西紫杉醇)±雷莫芦单抗

三类方案:化疗方案  

  • 曲氟尿苷/盐酸替吡嘧啶
  • 伊立替康

  2、N K细胞疗法是否对我有帮助?副作用是否可控?   X医生:目前尚没有证据表明NK细胞疗法对癌症有效,因此不予推荐。

3、口服替吉奥会腹泻,是否需要调整方案?   II/III期胃癌患者术后采用辅助治疗方案,分别为:

  • 替吉奥口服 1 年(口服 4 周,停药 2 周,共 8 个疗程或口服 2 周,停药 1 周,共 16个疗程)
  • CAPOX (卡培他滨+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)
  • SOX (替吉奥+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)

这三种方案中,替吉奥方案和CAPOX方案等效,但SOX要优于替吉奥。另外,胃癌术后直接使用纳武单抗免疫治疗无意义。

替吉奥确实会出现腹泻等代表性不良反应,患者可以考虑对症治疗,比如调节肠道的药物、止泻药等缓解副作用。如果副作用太严重,那么可以考虑减少药物剂量。

替吉奥的标准用药剂量为120mg,但用量低于80mg无法达到预期效果。如果当前患者用药为100mg,那么为了降低副作用,可以减少剂量到80mg;但如果目前剂量已经是80mg,则无法进一步降低剂量,此时考虑更换方案为CAPOX方案替代。 如果不良反应严重到干扰日常生活,则患者可以选择停药,持续观察病情变化。

对于无淋巴结转移的II期B和II其C的患者,可选择使用1年帕博丽珠单抗免疫治疗。

4 、术后患者很瘦,味觉障碍,如何调理改善?   通常,手术后患者体重会减轻20%左右。这是患者消化吸收能力低下、促食欲的胃肠激素减少引起的。大约6个月到1年时间,患者可以恢复正常。

味觉障碍可能是抗癌药的副作用引起的,也可能是饮食减少导致缺乏锌等微量元素引起的。建议患者采用少食多餐的方式饮食,每天分5-6次吃饭。在日本,我们有时也会给患者用一些营养补充剂。

另外,也可以考虑采用中草药的对症治疗,改善症状,比如十全大补汤、六君子汤。 会诊结束后,李女士的心情得到了极大的平复。她对自己未来要走的路更清晰了,也对日本专家的细致指导和会诊的快速响应非常满意。

中国是消化道癌症发病数量较多的国家,根据国家癌症中心发布的《2022年中国恶性肿瘤疾病负担情况》数据,2022年我国胃癌新发病例约为35.87万例,死亡人数26.04万人。

总体来说,胃癌属于严重威胁我国国民生命健康的蕞常见癌症之一。胃癌如能在早、中期发现,还是有很大机会通过手术实现根治的,患者仍有一定机会得到临床治愈(术后5年不复发即为临床治愈)。

但在胃癌患者中,一部分人会因为【年龄较高】、伴有诸多【基础病】等问题,对手术存有疑虑,担心“下不来手术台”,甚至会放弃手术机会,选择吃药等姑息治疗。这样的选择真的正确吗?现如今的技术能否支持这类老年患者安全手术呢?接下来,我们一起看一个真实案例。

01七旬老人遭遇中期胃癌

一位七十多岁的“老胃病”项女士,因短时间体重骤降(8斤)前往就医。血液检测显示,她有一项指标异常升高。进一步检查发现,她的食道和胃连接的地方(贲门)以及胃的“外墙”(胃壁)都变得异常的厚,而且形状不均匀——这正是胃癌常见的表现。

医生随后通过胃镜检查和病例活检(取一小块组织观察上面的细胞),确诊了老人患有胃癌。由于还没有出现胃以外的远处其他器官的转移,也没有附近淋巴结转移,因此项女士的胃癌分期为中期。虽不是早期,但中期胃癌通常是可以手术的。为项女士提供诊疗的医生也表示,可以通过全胃切除手术实现根治。

但一来项女士已经七十多岁,二来她有20多年的糖尿病(手术伤口会更慢愈合、感染风险高、术后并发症风险高)、右肺还有一枚1.2厘米的肺结节。种种问题让老人和家人们都比较犹豫,担心扛不住治疗,最终“越治越糟”。在这样的背景下,项女士决定找一位足够权威的外科专家,来为自己进行全面评估,看看能不能兼顾好肿瘤根治以及手术的安全性。

不久后,项女士预约了来自日本癌研有明医院消化中心胃外科部长布部创也医生为自己提供指导。

02日本专家咨询内容分享

在充分了解了项女士的病情信息和全部资料后,布部创也医生给出了如下指导建议:首先,患者此前接受的是普通CT而非增强CT,胃镜也没有清晰展示食道上肿瘤具体侵犯的程度,因此很难得出精准的分期判断。

后面患者来癌研有明医院就医时,医疗团队会在治疗前为她做一套非常精细、全面的检查,此后就可以明确肿瘤情况了。届时如果发现患者的分期、肿瘤侵犯的范围确实和现在的结果相同,那么可以通过一个腹腔镜微创手术实现根治,损伤会非常小;如果届时发现肿瘤侵犯食道过多,则需要消化道联合食道外科共同进行胸腔镜手术治疗。

但无论是哪一种情况,患者都可以耐受手术,并且保留一部分胃。癌研有明医院是一家极为擅长肿瘤微创手术的知名癌症专科医院。在胃癌方面,2005年,医院开始导入腹腔镜,2019年又引入了达芬奇手术机器人,患者术后并发症更少了。如今,癌研有明医院98%的外科手术都采用微创。

受益于此,很多在别的医院需要胃全切的胃癌患者,到癌研有明后可以保留一部分胃,还能兼顾临床治愈。这对于术后患者的长期营养摄入和体重维持都很有帮助。布部创也医生所在科室的主要目标之一,正是在做到根治性切除的前提之下,将原本的胃全切术式变为次全胃切除术,尽可能为患者保留一些胃,让他们未来的生活质量得到提升。

那么项女士的糖尿病问题,会不会影响到手术呢?对此,布部创也医生认为完全不必担心,因为对于这类患者,癌研有明医院会进行详细的术前评估,并且有专业团队介入,从生活方式调整和专业治疗入手,帮助患者控制好血糖,让血糖水平达到符合手术的标准,从而降低术后愈合不良风险。

关于肺部的1.2厘米结节,布部医生认为可以暂不处理,无论它到底是良性还是恶性。因为这枚结节属于纯磨玻璃结节,即便是恶性,进展也非常缓慢,并不会快速出现转移扩散。而胃癌根治手术虽然会采用微创方式,但依然会给患者带来一定的负担,如果同时处理肺结节,会导致负担过重、患者难以承受。所以当前蕞好的处理办法,是先集中精力解决胃癌肿瘤,术后安排呼吸科专家为患者进行肺结节诊断,给出随访或手术或根治性放疗的建议。

03项女士术后,是否需要化疗来降低复发风险、争取更大治愈希望?

对此,布部创也医生表示,是否化疗现在还不能判断。因为术后患者能获得蕞精准的分期判断,有可能患者术前被认为是2期,但实际上术后成了1期(无需化疗);有时也可能患者术前是1期,但术后成了2-3期。假如是2-3期,则患者术后需要坚持1年的辅助化疗,大概可以降低10%的复发风险。

当地时间10月29日礼来宣布了Ⅲb期临床试验(TRAILBLAZER-ALZ 6)的积极结果,对于早期症状性阿尔茨海默病成人患者,用改良滴定方案接受donanemab治疗的患者在24周主要终点时,伴水肿/积液的淀粉样蛋白相关影像学异常(ARIA-E)有所减少。

donanemab这个新药在今年7月获批于美国,又在之后获日本厚生劳动省、英国药品和医疗产品监管局批准,用于轻度阿尔茨海默病、轻度认知功能障碍的治疗。donanemab在国内2023年取得突破性治疗药物认定,并纳入优先审评审批程序,目前还在审评审批过程中。

CDE官网截图

但在FDA说明书中有黑框警告,大意是应用该药时应注意淀粉样蛋白相关影像学异常(ARIA),表现为ARIA-E和ARIA伴含铁血黄素沉积(ARIA-H),通常发生在治疗早期,且无症状,很少发生严重和危及生命的事件。本次试验的积极结果和这个黑框警告相关。一起来看详情。

FDA说明书截图

给药方式有哪些改变?会不会影响效果?

TRAILBLAZER-ALZ 6是一项多中心随机双盲Ⅲb期研究,主要研究donanemab的不同给药方案对早期症状性AD患者ARIA-E和淀粉样蛋白清除率的影响,这里的早期AD指的是轻度认知障碍(MCI)和轻度痴呆疾病阶段。

给药方式和既往不同,既往标准给药方案是在前三次输注时接受2瓶(700mg)donanemab,然后再接受4瓶(1400mg);改良滴定方式是患者第一次输注1瓶(350mg),第二次输注2瓶(700mg),第三次输注3瓶(1050mg),此后每次输注4瓶(1400mg)。

研究的主要终点是第24周时患者出现ARIA-E占总参与者的比例,结果显示接受改良滴定方式的患者ARIA-E发生率为14%,而标准给药方案为24%,相对风险降低41%。载脂蛋白E(APOE)是已知的阿尔茨海默病遗传风险因素的携带者,在这些患者中,19%患者在改良滴定时患有ARIA-E,而标准给药方案中为57%,相对风险降低67%。

看到这里你或许也有疑问,虽然ARIA-E的发生风险降低了,但改良滴定方案会不会影响疗效?答案是不会。

与接受标准给药方案的患者相比,改良滴定患者淀粉样斑块和p-tau217减少。改良滴定的患者的淀粉样斑块水平较基线平均降低 67%,而标准给药组患者为69%。

参考来源

1.Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase Ⅲb study.

2.CED官网.

3.A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6).

当地时间10月29日,阿西米尼(asciminib)获美国食品药品管理局(FDA)加速批准[1] ,用于慢性期新诊断的费城染色体阳性慢性粒细胞白血病(Ph+CML)成年患者。CML是一种骨髓和血细胞癌症,通常由费城染色体的异常染色体引起。在一线治疗中,约1/3的患者会出现下列问题:由于不良反应或者治疗无效而停止酪氨酸激酶抑制剂(TKI)治疗。

为了解决这一问题,需要开发新的药物,asciminib就是解决这一困境的新药。早在2022年8月,加拿大药物和卫生技术局(CADTH)建议[2] :“若满足条件,可通过公共药物计划报销asciminib用于治疗费城染色体阳性慢性粒细胞白血病。”

asciminib为何得到FDA的青睐?

本次获批基于一项III期多中心随机研究,研究目的是比较每日80mg的asciminib与TKI治疗的疗效。TKI治疗是接受伊马替尼、尼洛替尼、达沙替尼或博舒替尼任意一种治疗。

共有405名患者被随机分配(1:1)进两组治疗。主要疗效结局指标是48周时的主要分子反应(MMR)率。这个指标是慢性髓性白血病的关键指标,这个比例越高,说明该治疗在基因水平上对疾病的控制效果越好,能够更有效地抑制疾病相关基因的表达,进而有望更好地控制疾病的进展、改善患者的症状和预后。

研究结果显示,48周时MMR率方面,asciminib组中为68%(95% CI: 61, 74),TKI组为49%(95% CI: 42, 56),二者相差19%。细看具体的TKI,入组伊马替尼和其他TKI药物入组比例为1:1;asciminib组的MMR率为69%(95% CI: 59, 78),而伊马替尼组为40%(95% CI: 31, 50),相差近30%(95% CI: 17, 42)。

这个新药安全吗?每周需要打几次药?

根据FDA数据显示,在新诊断和既往接受过治疗的患者,应用新药最常见的不良反应(≥20%)是肌肉骨骼疼痛、皮疹、疲劳、上呼吸道感染、头痛、腹痛和腹泻。若只看新诊断的患者,最常见的实验室异常(≥40%)是淋巴细胞计数降低、白细胞计数降低、血小板计数降低、中性粒细胞计数降低等。

根据FDA已批准的asciminib说明书,用药期间还需要注意一下事项:

1.骨髓抑制 :用药期间可能因出现骨髓抑制,发生血小板减少症、中性粒细胞减少症和贫血。用药应在治疗的前3个月,需要每两周进行一次全血细胞计数,此后每月进行一次检测,从而判断患者有无骨髓抑制症状。根据严重程度,咨询医生是否需要停药。

2.胰腺毒性 :患者可能出现血清脂肪酶和淀粉酶无症状升高,每月需评估血清脂肪酶和淀粉酶水平,如果您有胰腺炎,则注意主动告知医生,需要进行频率更高的检测。

3.高血压风险 :可能出现3级或4级高血压风险,应注意检测血压。

4.超敏反应 :可能出现3级或4级超敏反应,包括皮疹、水肿和支气管痉挛。如果出现这些症状,需及时反馈医生,医生会根据超敏反应的体征和症状,开始适当的治疗。

5.心血管毒性 :如果您有心血管病史,需要告知医生;对于3级或更高级别的心血管毒性,医生会考虑暂停用药、减少剂量或永久停药。

6.胚胎/胎儿毒性 :若您在怀孕期间用药或在服用药物期间怀孕,可能对孩子有潜在风险。这个新药是口服药,需要根据不同的给药剂量(80mg或40mg)每天/或每两天用药。

近些年来,还有哪些白血病药物获批FDA?

根据FDA肿瘤学/血液系统恶性肿瘤批准通知,白血病相关新药整理如下表。

另外可以看出21年时asciminib已获批白血病治疗,但限定既往接受过两种或更多TKIs治疗,本次获批属于扩大适应证。

参考来源:

1.FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia. 2.Asciminib(Scemblix):CADTHReimbursementRecommendation:Indication:ForthetreatmentofadultpatientswithPhiladelphiachromosome-positivechronicmyeloidleukemia(Ph+CML)inchronicphase(CP)previouslytreatedwith2ormoretyrosinekinaseinhibitors.Ottawa(ON):CanadianAgencyforDrugsandTechnologiesinHealth;2022Aug.PMID:38713779. 3.AStudyofOralAsciminibVersusOtherTKIsinAdultPatientsWithNewlyDiagnosedPh+CML-CP. 4.Product information:SCEMBLIX-asciminibtablet,filmcoated.UpdatedAugust7,2024. 5.Oncology(Cancer)/HematologicMalignanciesApprovalNotifications.

以下内容来源于新英格兰医学杂志。

Presentation of Case

Dr. Carrie Chui (Neurology): A 79-year-old man was admitted to this hospital because of involuntary movements on the left side and transient unresponsiveness.
The patient had been in his usual state of health until 9 months before admission, when involuntary movements of the left shoulder and left side of the face developed. The movements were described by the patient as twitching, were not associated with a change in the level of consciousness, and resolved after 1 to 2 minutes. During the next 6 months, the patient had similar episodes approximately once per month, but the episodes increased in duration, lasting 5 to 6 minutes.
Three months before admission, the episodes of involuntary movements increased in frequency, and the patient was evaluated by his primary care physician. The physical examination was normal. Results of kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 129 mmol per liter (reference range, 135 to 145). There was a history of inappropriate antidiuretic hormone secretion, and the sodium level was similar to levels obtained during the past 4 years. Magnetic resonance imaging (MRI) of the head (Figure 1A), performed before and after the administration of intravenous contrast material, revealed a focus of enhancement in the right middle frontal gyrus that was thought to be a small vascular anomaly. Electroencephalography (EEG), performed with the patient in awake and drowsy states, revealed rare, brief, focal slowing in the left temporal lobe during drowsiness; no epileptiform abnormalities were present.
Figure 1
MRI of the Head and CT Angiogram of the Head and Neck.
Two months before admission, the patient was evaluated in the epilepsy clinic affiliated with this hospital. He reported that the episodes of involuntary movements had increased in both frequency and duration, occurring once or twice per day and lasting approximately 10 minutes. Episodes began with tingling and numbness in the left leg that prompted the patient to voluntarily stomp the left foot to relieve the uncomfortable sensation. Then, the patient had involuntary movements that he described as an uncontrollable invisible force moving the left leg and arm, with hyperextension of the arm backward and pronation of the wrist. There was associated numbness in the distal portions of the left third, fourth, and fifth fingers and involuntary movement of the left cheek. No prodromal symptoms occurred. The patient had awareness during the episodes, and after the episodes, he felt fatigued but had a normal level of consciousness, without confusion. The examination in the epilepsy clinic was normal. A diagnosis of seizure disorder was considered, and treatment with levetiracetam was started.
Three weeks before admission, the patient was again evaluated in the epilepsy clinic. He reported that the episodes of involuntary movements still occurred on a daily basis but had decreased in duration and involved only the left leg, without abnormal movements of the arm or face. Dizziness, headache, and weakness had developed and were attributed to the use of levetiracetam. The patient’s family had recorded a video of one of the episodes of involuntary movements. After reviewing the video, the patient’s neurologist thought that the episodes were less likely to be caused by seizures and more consistent with choreoathetoid movements. Cross-tapering of medications — with the simultaneous administration of levetiracetam in decreasing doses and clobazam in increasing doses — was initiated, and the patient was referred to the movement disorders clinic affiliated with this hospital.
On the morning of admission, an episode of involuntary movements of the left leg and left shoulder occurred and persisted for 1 hour. Several hours after the symptoms abated, the patient’s wife found the patient to be unresponsive; he was sitting in a chair. Emergency medical services were called, and when they arrived, the patient was responsive. The fingerstick blood glucose level was 180 mg per deciliter (10.0 mmol per liter) and the blood pressure 110/80 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the patient reported dysuria and increased urinary frequency. The patient’s daughter noted that he had been more anxious during the past 3 years and occasionally had trouble with memory. Other medical history included Barrett’s esophagus, benign prostatic hypertrophy, chronic hepatitis B virus infection, eczema, gastroesophageal reflux disease, hypertension, nonischemic cardiomyopathy, and osteoporosis. There was no history of head trauma or extended loss of consciousness. Medications included aspirin, atorvastatin, doxazosin, finasteride, omeprazole, metoprolol, sacubitril, and valsartan. There were no known drug allergies. The patient was a lifelong nonsmoker and drank alcohol rarely; he did not use illicit drugs. His mother had had gastric cancer, and his sister had had esophageal cancer; there was no family history of seizures.
On examination, the temporal temperature was 36.8°C, the blood pressure 152/97 mm Hg, the pulse 65 beats per minute, the respiratory rate 16 breaths per minute, and the oxygen saturation 96% while the patient was breathing ambient air. The body-mass index (the weight in kilograms divided by the square of the height in meters) was 21.7. The blood pressure decreased to 130/63 mm Hg with standing. The patient was alert and interactive. The lower jaw was held to the left, but the nasolabial folds and smile were symmetric with activation. There were nonrhythmic, nonstereotyped, writhing movements of the left arm. Tone was normal, and strength was assessed as 5 out of 5 in the arms and legs. Results of liver-function and kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 125 mmol per liter. The lactate level was 2.1 mmol per liter (19 mg per deciliter; reference range, 0.5 to 2.0 mmol per liter [5 to 18 mg per deciliter]). The urinalysis was normal. Intravenous fluids were administered. Imaging studies were obtained.
Dr. Rajiv Gupta: Computed tomographic (CT) angiography of the head and neck (Figure 1B) revealed extensively calcified plaque with severe stenosis of the distal right common carotid artery (CCA), extending into the proximal right internal carotid artery (ICA), as well as stenosis of the right and left paraclinoid ICAs and the left vertebral artery at its origin. There was no vascular abnormality on the CT angiogram that corresponded to the abnormality in the right middle frontal gyrus seen on the previous MRI.
Dr. Chui: The patient was admitted to the hospital. On the second hospital day, the sodium level had increased to 130 mmol per liter, and the lactate level was normal. Additional imaging studies were obtained.
Dr. Gupta: MRI of the head showed no evidence of acute infarction. The focus of enhancement in the right frontal lobe that had been noted previously was not seen on the current MRI.
Dr. Chui: Blood levels of thyrotropin, cobalamin, and glycated hemoglobin and results of coagulation tests were normal. Screening tests for Lyme disease, tuberculosis, and syphilis were negative, as were tests for antibodies to cardiolipin and β2-glycoprotein. A test for antinuclear antibodies was positive, at a titer of 1:160 in a homogeneous pattern. During a physical therapy session, the patient had abnormal movements of the left leg, left arm, and left side of the face. The abnormal movements diminished when the patient used distraction techniques, such as thigh tapping, finger snapping, and walking while holding a glass of water.
The transient unresponsiveness that led to the patient’s admission was attributed to a combination of sedation from clobazam and hypovolemia. Treatment with clobazam was stopped, and hydration was encouraged. A diagnosis of functional neurologic disorder was considered; outpatient physical therapy with continued use of distraction techniques was recommended. The patient was discharged home on the third hospital day.
Episodes of involuntary movements continued to occur on a daily basis at home. Two weeks after discharge, when the patient was doing exercises while sitting in a chair and having a conversation with his wife, he suddenly stopped talking. She found him slumped in the chair with his eyes closed, no longer exercising. When she asked him questions, he repeatedly said “yes.” Emergency medical services were called, and when they arrived, the patient was alert, diaphoretic, and nonverbal. He had a facial droop on the left side and a right gaze preference. The fingerstick blood glucose level was 130 mg per deciliter (7.2 mmol per liter) and the blood pressure 120/60 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the temporal temperature was 36.6°C, the blood pressure 143/63 mm Hg, the pulse 66 beats per minute, the respiratory rate 18 breaths per minute, and the oxygen saturation 98% while the patient was breathing ambient air. He was alert and interactive. There was a facial droop on the left side. There was no effort against gravity in the left arm. The patient was able to lift the left leg off the bed for 1 to 2 seconds. He had a right gaze deviation that could not be overcome and mild dysarthria. The remainder of the examination was normal. A diagnosis of stroke was considered, and emergency CT angiography was performed.
Dr. Gupta: CT angiography showed no evidence of acute territorial infarction and no changes in cerebrovascular disease.
Dr. Chui: On repeat physical examination performed after CT angiography, the gaze deviation and dysarthria had resolved, and strength was normal. Mild facial paralysis was present.
A diagnosis was made.

Differential Diagnosis

Dr. Albert Y. Hung: This 79-year-old man initially presented with involuntary movements of the left shoulder and face without associated loss of consciousness. Diagnosis of an unusual movement disorder, especially one that is present episodically, can be challenging. Videos brought in by the patient can be very useful. 1 Most movement disorders result from abnormal functioning of extrapyramidal circuits involving the basal ganglia, rather than a specific neuroanatomical lesion, and the first step toward diagnosis is to identify the type of abnormal movements. 2
Four salient aspects of this patient’s involuntary movements can help in characterizing the movement disorder before generating a differential diagnosis. First, the movements were paroxysmal, lasting for short periods of time with resolution between episodes. Second, the movements were nonstereotyped, appearing randomly and variably. Third, the movements were restricted to the left side of his body throughout the course, localizing the disease process to the right cerebral hemisphere. Finally, the symptoms were progressive, increasing in both duration and frequency.

Movement Disorders

This patient had abnormal involuntary movements, symptoms indicative of a hyperkinetic movement disorder. Tremor, the most common hyperkinetic disorder, is unlikely because the patient did not have rhythmic movements. Dystonia is also unlikely, because he did not have sustained muscle contractions that were causing twisting or abnormal postures of the legs, arms, head, neck, or face. Although the patient initially described the movements as twitching, his later descriptions are not suggestive of myoclonus or tics, which manifest as sudden, rapid, recurrent movements.
This patient’s neurologist described the involuntary movements as “choreoathetoid” after reviewing a video of an episode. Chorea, athetosis, and ballism make up a spectrum of involuntary movements that often occur in combination. Chorea refers to involuntary movements that are “dancelike” — irregular, random, unintended, and flowing from one body part to another. When these movements are slow and writhing (with a lower amplitude) and involve the distal limbs, the term athetosis is used. The presence of both chorea and athetosis in the same patient is referred to as choreoathetosis. When the movements are fast and flinging (with a higher amplitude) and involve the proximal limbs, the term ballism is used. Although the description of this patient’s movements was not clearly suggestive of ballism, hemichorea and hemiballismus often occur together.
The term dyskinesia can refer to any abnormal movements and is often used to describe hyperkinetic disorders that are induced by specific drugs, such as tardive dyskinesia induced by dopamine antagonists or dyskinesia induced by levodopa in patients with Parkinson’s disease. Often, dyskinesia manifests as chorea or choreoathetoid movements, but chorea and dyskinesia are not synonymous. This patient appears to have involuntary dyskinesia with choreoathetosis as the primary phenomenology. Before constructing a differential diagnosis for dyskinesia in this patient, I will consider two conditions that mimic dyskinesia: seizures and functional movement disorder.

Seizures

Various movement disorders may be mistaken for seizures, although these movement disorders are not associated with EEG abnormalities during the episode. Patients with some forms of epilepsy may present with abnormal movements without other features that are typically associated with seizures, such as aura, change in responsiveness, incontinence, or a postictal state. 3,4 Seizures were initially suspected in this patient, and he was referred to the epilepsy clinic. Recurrent focal seizures were probably suspected because of the transient nature of the episodes. Initial MRI had shown a small abnormality in the right middle frontal gyrus, but this finding was not seen on follow-up imaging, which makes it unlikely to be related to the overall presentation. Baseline EEG had shown only brief left temporal slowing, without epileptiform abnormalities. The EEG was an interictal study, so the findings do not rule out seizures. However, the slowing was ipsilateral to the abnormal movements, so it is unlikely to be related to the episodes. In addition, the patient’s involuntary movements were nonstereotyped and nonrhythmic, which makes his presentation unlikely to be due to a seizure disorder.

Functional Movement Disorder

Because this patient’s movements diminished with the use of distraction techniques, a diagnosis of functional movement disorder was considered. Most cases of functional movement disorder begin abruptly after a trigger, such as a mild physical injury or illness; a psychological stressor can be present but is not required for diagnosis. Symptoms are typically most severe around the time of onset and may wax and wane over time. Although distractibility is a finding associated with functional disorders, abnormal movements that occur with nonfunctional syndromes can sometimes be suppressed by action or incorporated into voluntary movements in a manner that may appear distractible. Several clinical features in this patient make a diagnosis of functional disorder unlikely. Functional movement disorder is more common in women than in men, and the average age at onset is 40 years. 5 In addition, tremor is the most common clinical phenotype seen in patients with functional movement disorder; chorea or choreoathetosis, which was seen in this patient, is very unusual in patients with functional movement disorder. Overall, functional movement disorder is unlikely to explain this patient’s presentation.

Dyskinesia

Primary paroxysmal dyskinesia refers to a group of heterogeneous syndromes characterized by recurrent involuntary movements that occur episodically and abruptly, without loss of consciousness. 6 These disorders usually begin in childhood or young adulthood. Both the age of this patient and the described phenomenology make a diagnosis of primary paroxysmal dyskinesia unlikely.
The differential diagnosis in this case is therefore focused on causes of secondary dyskinesia, of which there are many. 7 MRI ruled out the presence of a mass lesion suggestive of cancer. The patient had no history of acute illness suggestive of a viral or other infectious encephalitis, and there was no history of trauma or exposure to drugs or other toxins. Although his daughter mentioned trouble with memory, there was no compelling history suggestive of a neurodegenerative disease.
A common metabolic cause of secondary dyskinesia is diabetic striatopathy, a syndrome involving the acute-to-subacute onset of chorea and ballism in the context of hyperglycemia. 8 This syndrome can occur as the initial manifestation of type 2 diabetes mellitus or as a complication of poorly controlled diabetes. Diabetic striatopathy is more likely to develop in women than in men, and the average age at onset is 70 years. Most patients present with hemichorea and hemiballismus, rather than bilateral symptoms. CT shows hyperdensity, and T1-weighted MRI shows hyperintensity, in the contralateral basal ganglia. However, this patient had no history of diabetes and had a normal blood glycated hemoglobin level, features that rule out a diagnosis of diabetic striatopathy.
Choreiform movements can also be a manifestation of autoimmune conditions. 9 This patient’s initial presentation with unilateral shoulder and face movements would have suggested the possibility of faciobrachial dystonic seizures associated with anti–leucine-rich, glioma-inactivated 1 (anti-LGI1) encephalitis. 10 This condition is often associated with hyponatremia, which was present in this patient. However, as the case evolved, leg involvement and sensory changes developed that would be atypical for anti-LGI1 encephalitis.
One key clue in this case is that the patient did not have an isolated movement disorder. In addition to motor symptoms, he had a variety of sensory symptoms involving both the left arm and the left leg. His first hospital admission was precipitated by an episode of unresponsiveness. The clinical event that led to his second presentation to the emergency department was distinctly different: an acute onset of speech difficulty accompanied by left hemiparesis and right gaze deviation that was worrisome for an acute right middle cerebral artery (MCA) syndrome. The symptoms resolved without intervention, which indicates that he may have had an acute transient ischemic attack (TIA). The most relevant imaging finding was severe cerebrovascular disease, including severe stenosis of the distal right CCA and proximal right ICA. Could this patient’s movement disorder be explained by a vascular lesion?

Limb-Shaking TIAs

Limb-shaking TIAs were first described by C. Miller Fisher in 1962. 11 In most case reports, these episodes are associated with high-grade stenosis of the ICA, which was seen in this patient. 12,13 The mechanism is thought to be cerebral hypoperfusion, and changes in posture or head position that decrease cerebral blood flow can precipitate these episodes. In this patient, the first episode of unresponsiveness that led to hospital admission occurred when he was sitting. He then had an acute episode involving right gaze preference that was provoked by exercise and was very suggestive of a TIA in the right MCA territory. These findings are highly suggestive of a diagnosis of limb-shaking TIAs, and I would refer this patient for emergency carotid endarterectomy.

Clinical Impression and Initial Management

Dr. Scott B. Silverman: When I evaluated this patient, his transient right gaze preference and left hemiparesis were consistent with a right MCA syndrome due to a TIA from symptomatic severe stenosis of the right ICA. The mechanism of this event was either artery-to-artery embolism or hypoperfusion. His previous, recurrent episodes of transient choreoathetosis on the left side that had occurred mainly while he was sitting, standing, or exercising were consistent with limb-shaking TIAs from hypoperfusion or low flow.
The pathogenesis of a low-flow state related to severe carotid stenosis resulting in limb-shaking TIAs is described in a small case series. 14 In six out of eight patients, the transient, stereotyped, involuntary movements were eliminated with carotid artery revascularization. Positional cerebral ischemia in patients without orthostatic hypotension has been described. 15
Treatment with atorvastatin was continued, the dose of aspirin was increased to 325 mg per day, and an intravenous heparin infusion was started. The strategy of permissive hypertension was used, with high blood pressure allowed to a maximum systolic blood pressure of 180 mm Hg. The patient was admitted to the stroke service, and carotid artery duplex ultrasonography was performed.
Dr. Gupta: Doppler ultrasonography of the carotid arteries (Figure 2) revealed markedly elevated Doppler flow velocities within the proximal right ICA. There was a parvus et tardus waveform in the distal right ICA, a finding indicative of low flow related to the more proximal high-grade stenosis. The Doppler waveform contours had poststenotic turbulence.
Figure 2
Doppler Ultrasound Image.
Dr. Silverman: The vascular surgery service was consulted, and the patient underwent right carotid endarterectomy.

Clinical Diagnosis

Limb-shaking transient ischemic attacks.

Dr. Albert Y. Hung’s Diagnosis

Limb-shaking transient ischemic attacks due to severe carotid stenosis, with secondary paroxysmal dyskinesia.

Pathological Discussion

Dr. Caroline F. Hilburn: The endarterectomy specimen included the carotid bifurcation and was notable for firm arterial walls, a finding consistent with calcification. On gross examination (Figure 3A), a large plaque was centered at the carotid bifurcation and protruded into the lumen, resulting in a maximal luminal stenosis of 80%. The plaque had an irregular and focally friable surface. On microscopic examination (Figure 3B), the plaque was characterized by extensive calcification. Some regions of the plaque had a smooth, healed fibrous cap, whereas other regions had an irregular surface suggestive of ulceration, which indicated potential sites of plaque rupture. Multiple smaller calcified plaques were present, affecting both branches of the artery.
Figure 3
Endarterectomy Specimen.

Pathological Diagnosis

Complex atherosclerotic plaque with portions of attached media.

Additional Management

Dr. Silverman: After the procedure, the patient had an uneventful recovery and was discharged home on the fifth hospital day. He was seen 1 month after discharge in the stroke prevention clinic. There had been no further episodes of involuntary movements or choreoathetosis and no stroke or TIA. The patient continues to take aspirin, atorvastatin, and antihypertensive medications.

Final Diagnosis

Limb-shaking transient ischemic attacks.
药品使用说明
打开京东APP
实惠又轻松
打开京东APP
京ICP备11041704号
京公网安备 11000002000088号